Abstract:Objective To investigate the effects of bilateral subthalamic nucleus deep brain stimulation (STN-DBS) on the cognition, depression, and anxiety of patients with Parkinson's disease (PD).Methods Sixteen PD patients undergoing bilateral STN-DBS were consecutively enrolled as subjects and assigned to experimental group. The cognition, depression, and anxiety of the patients were evaluated at 1 week before surgery and 1 and 3 weeks after surgery. Sixteen PD patients undergoing optimized drug treatment within the same period were assigned to control group. The control group was evaluated by the same neuropsychological scales at the same time points as the experimental group.Results In the experimental group, the scores for Montreal Cognitive Assessment at 1 and 3 weeks after surgery were slightly lower than that at 1 week before surgery (19.81±4.34 vs 20.69±4.33, P>0.05; 19.44±5.35 vs 20.69±4.33, P>0.05); patients showed significant improvement in depression at 1 and 3 months after surgery (11.94±6.16 vs 23.56±14.60, P<0.05; 7.38±5.18 vs 23.56±14.60, P<0.05); patients also showed significant improvement in anxiety at 1 and 3 months after surgery (15.13±5.62 vs 22.13±6.11, P<0.05; 8.00±6.76 vs 22.13±6.11, P<0.05). The improvement in depression and anxiety was not correlated with UPDRS part Ⅲ at any time point.Conclusions Bilateral STN-DBS does not affect the global cognitive function of PD patients at 3 months after surgery. However, the changes in the cognitive domains require a more detailed assessment by the neuropsychological scales. Bilateral STN-DBS can significantly improve the depression and anxiety of PD patients in the short term.The improvemet of depression and anxiety was not correlated with the improvement of motor symtoms at any time points.